img

Global Novel Oral Anticoagulants Drugs Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Novel Oral Anticoagulants Drugs Market Research Report 2024

Anticoagulant drugs (also known as blood thinners) are chemical substances that prevent or reduce coagulation of blood and prolong the blood clotting time.
According to MRAResearch’s new survey, global Novel Oral Anticoagulants Drugs market is projected to reach US$ 42200 million in 2033, increasing from US$ 21420 million in 2022, with the CAGR of 10.2% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Novel Oral Anticoagulants Drugs market research.
The antithrombotic treatment market is driven by the increasing prevalence of cardiovascular diseases and the rising aging population, which are significant risk factors for thrombotic disorders. Antithrombotic therapies, including antiplatelet and anticoagulant drugs, play a crucial role in preventing and treating thrombotic events, such as heart attacks and strokes. The growing adoption of these treatments for various thrombotic indications, along with advancements in drug development and personalized medicine, further propel market growth. However, challenges include balancing the risk of bleeding complications with the benefits of preventing thrombotic events, ensuring optimal dosing and adherence to treatment regimens, and addressing the cost burden of long-term therapy. Overcoming these challenges through continuous research, improved patient education, and collaboration between healthcare providers and pharmaceutical companies will be crucial for the sustained growth of the antithrombotic treatment market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Novel Oral Anticoagulants Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Bristol-Myers Squibb
Bayer
Pfizer
Johnson & Johnson
Boehringer Ingelheim
Daiichi Sankyo
Segment by Type
Direct Thrombin Inhibitor
Factor Xa Inhibitors

Segment by Application


Hospital
Drugs Stores
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Novel Oral Anticoagulants Drugs report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Novel Oral Anticoagulants Drugs Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Direct Thrombin Inhibitor
1.2.3 Factor Xa Inhibitors
1.3 Market by Application
1.3.1 Global Novel Oral Anticoagulants Drugs Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospital
1.3.3 Drugs Stores
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Novel Oral Anticoagulants Drugs Market Perspective (2018-2033)
2.2 Novel Oral Anticoagulants Drugs Growth Trends by Region
2.2.1 Global Novel Oral Anticoagulants Drugs Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Novel Oral Anticoagulants Drugs Historic Market Size by Region (2018-2023)
2.2.3 Novel Oral Anticoagulants Drugs Forecasted Market Size by Region (2024-2033)
2.3 Novel Oral Anticoagulants Drugs Market Dynamics
2.3.1 Novel Oral Anticoagulants Drugs Industry Trends
2.3.2 Novel Oral Anticoagulants Drugs Market Drivers
2.3.3 Novel Oral Anticoagulants Drugs Market Challenges
2.3.4 Novel Oral Anticoagulants Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Novel Oral Anticoagulants Drugs Players by Revenue
3.1.1 Global Top Novel Oral Anticoagulants Drugs Players by Revenue (2018-2023)
3.1.2 Global Novel Oral Anticoagulants Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Novel Oral Anticoagulants Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Novel Oral Anticoagulants Drugs Revenue
3.4 Global Novel Oral Anticoagulants Drugs Market Concentration Ratio
3.4.1 Global Novel Oral Anticoagulants Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Novel Oral Anticoagulants Drugs Revenue in 2022
3.5 Novel Oral Anticoagulants Drugs Key Players Head office and Area Served
3.6 Key Players Novel Oral Anticoagulants Drugs Product Solution and Service
3.7 Date of Enter into Novel Oral Anticoagulants Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Novel Oral Anticoagulants Drugs Breakdown Data by Type
4.1 Global Novel Oral Anticoagulants Drugs Historic Market Size by Type (2018-2023)
4.2 Global Novel Oral Anticoagulants Drugs Forecasted Market Size by Type (2024-2033)
5 Novel Oral Anticoagulants Drugs Breakdown Data by Application
5.1 Global Novel Oral Anticoagulants Drugs Historic Market Size by Application (2018-2023)
5.2 Global Novel Oral Anticoagulants Drugs Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Novel Oral Anticoagulants Drugs Market Size (2018-2033)
6.2 North America Novel Oral Anticoagulants Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Novel Oral Anticoagulants Drugs Market Size by Country (2018-2023)
6.4 North America Novel Oral Anticoagulants Drugs Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Novel Oral Anticoagulants Drugs Market Size (2018-2033)
7.2 Europe Novel Oral Anticoagulants Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Novel Oral Anticoagulants Drugs Market Size by Country (2018-2023)
7.4 Europe Novel Oral Anticoagulants Drugs Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Novel Oral Anticoagulants Drugs Market Size (2018-2033)
8.2 Asia-Pacific Novel Oral Anticoagulants Drugs Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Novel Oral Anticoagulants Drugs Market Size by Region (2018-2023)
8.4 Asia-Pacific Novel Oral Anticoagulants Drugs Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Novel Oral Anticoagulants Drugs Market Size (2018-2033)
9.2 Latin America Novel Oral Anticoagulants Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Novel Oral Anticoagulants Drugs Market Size by Country (2018-2023)
9.4 Latin America Novel Oral Anticoagulants Drugs Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Novel Oral Anticoagulants Drugs Market Size (2018-2033)
10.2 Middle East & Africa Novel Oral Anticoagulants Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Novel Oral Anticoagulants Drugs Market Size by Country (2018-2023)
10.4 Middle East & Africa Novel Oral Anticoagulants Drugs Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bristol-Myers Squibb
11.1.1 Bristol-Myers Squibb Company Detail
11.1.2 Bristol-Myers Squibb Business Overview
11.1.3 Bristol-Myers Squibb Novel Oral Anticoagulants Drugs Introduction
11.1.4 Bristol-Myers Squibb Revenue in Novel Oral Anticoagulants Drugs Business (2018-2023)
11.1.5 Bristol-Myers Squibb Recent Development
11.2 Bayer
11.2.1 Bayer Company Detail
11.2.2 Bayer Business Overview
11.2.3 Bayer Novel Oral Anticoagulants Drugs Introduction
11.2.4 Bayer Revenue in Novel Oral Anticoagulants Drugs Business (2018-2023)
11.2.5 Bayer Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Novel Oral Anticoagulants Drugs Introduction
11.3.4 Pfizer Revenue in Novel Oral Anticoagulants Drugs Business (2018-2023)
11.3.5 Pfizer Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Detail
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Novel Oral Anticoagulants Drugs Introduction
11.4.4 Johnson & Johnson Revenue in Novel Oral Anticoagulants Drugs Business (2018-2023)
11.4.5 Johnson & Johnson Recent Development
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Detail
11.5.2 Boehringer Ingelheim Business Overview
11.5.3 Boehringer Ingelheim Novel Oral Anticoagulants Drugs Introduction
11.5.4 Boehringer Ingelheim Revenue in Novel Oral Anticoagulants Drugs Business (2018-2023)
11.5.5 Boehringer Ingelheim Recent Development
11.6 Daiichi Sankyo
11.6.1 Daiichi Sankyo Company Detail
11.6.2 Daiichi Sankyo Business Overview
11.6.3 Daiichi Sankyo Novel Oral Anticoagulants Drugs Introduction
11.6.4 Daiichi Sankyo Revenue in Novel Oral Anticoagulants Drugs Business (2018-2023)
11.6.5 Daiichi Sankyo Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Novel Oral Anticoagulants Drugs Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Direct Thrombin Inhibitor
Table 3. Key Players of Factor Xa Inhibitors
Table 4. Global Novel Oral Anticoagulants Drugs Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Novel Oral Anticoagulants Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Novel Oral Anticoagulants Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Novel Oral Anticoagulants Drugs Market Share by Region (2018-2023)
Table 8. Global Novel Oral Anticoagulants Drugs Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Novel Oral Anticoagulants Drugs Market Share by Region (2024-2033)
Table 10. Novel Oral Anticoagulants Drugs Market Trends
Table 11. Novel Oral Anticoagulants Drugs Market Drivers
Table 12. Novel Oral Anticoagulants Drugs Market Challenges
Table 13. Novel Oral Anticoagulants Drugs Market Restraints
Table 14. Global Novel Oral Anticoagulants Drugs Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Novel Oral Anticoagulants Drugs Market Share by Players (2018-2023)
Table 16. Global Top Novel Oral Anticoagulants Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Novel Oral Anticoagulants Drugs as of 2022)
Table 17. Ranking of Global Top Novel Oral Anticoagulants Drugs Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Novel Oral Anticoagulants Drugs Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Novel Oral Anticoagulants Drugs Product Solution and Service
Table 21. Date of Enter into Novel Oral Anticoagulants Drugs Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Novel Oral Anticoagulants Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Novel Oral Anticoagulants Drugs Revenue Market Share by Type (2018-2023)
Table 25. Global Novel Oral Anticoagulants Drugs Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Novel Oral Anticoagulants Drugs Revenue Market Share by Type (2024-2033)
Table 27. Global Novel Oral Anticoagulants Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Novel Oral Anticoagulants Drugs Revenue Market Share by Application (2018-2023)
Table 29. Global Novel Oral Anticoagulants Drugs Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Novel Oral Anticoagulants Drugs Revenue Market Share by Application (2024-2033)
Table 31. North America Novel Oral Anticoagulants Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Novel Oral Anticoagulants Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Novel Oral Anticoagulants Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Novel Oral Anticoagulants Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Novel Oral Anticoagulants Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Novel Oral Anticoagulants Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Novel Oral Anticoagulants Drugs Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Novel Oral Anticoagulants Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Novel Oral Anticoagulants Drugs Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Novel Oral Anticoagulants Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Novel Oral Anticoagulants Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Novel Oral Anticoagulants Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Novel Oral Anticoagulants Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Novel Oral Anticoagulants Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Novel Oral Anticoagulants Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 46. Bristol-Myers Squibb Company Detail
Table 47. Bristol-Myers Squibb Business Overview
Table 48. Bristol-Myers Squibb Novel Oral Anticoagulants Drugs Product
Table 49. Bristol-Myers Squibb Revenue in Novel Oral Anticoagulants Drugs Business (2018-2023) & (US$ Million)
Table 50. Bristol-Myers Squibb Recent Development
Table 51. Bayer Company Detail
Table 52. Bayer Business Overview
Table 53. Bayer Novel Oral Anticoagulants Drugs Product
Table 54. Bayer Revenue in Novel Oral Anticoagulants Drugs Business (2018-2023) & (US$ Million)
Table 55. Bayer Recent Development
Table 56. Pfizer Company Detail
Table 57. Pfizer Business Overview
Table 58. Pfizer Novel Oral Anticoagulants Drugs Product
Table 59. Pfizer Revenue in Novel Oral Anticoagulants Drugs Business (2018-2023) & (US$ Million)
Table 60. Pfizer Recent Development
Table 61. Johnson & Johnson Company Detail
Table 62. Johnson & Johnson Business Overview
Table 63. Johnson & Johnson Novel Oral Anticoagulants Drugs Product
Table 64. Johnson & Johnson Revenue in Novel Oral Anticoagulants Drugs Business (2018-2023) & (US$ Million)
Table 65. Johnson & Johnson Recent Development
Table 66. Boehringer Ingelheim Company Detail
Table 67. Boehringer Ingelheim Business Overview
Table 68. Boehringer Ingelheim Novel Oral Anticoagulants Drugs Product
Table 69. Boehringer Ingelheim Revenue in Novel Oral Anticoagulants Drugs Business (2018-2023) & (US$ Million)
Table 70. Boehringer Ingelheim Recent Development
Table 71. Daiichi Sankyo Company Detail
Table 72. Daiichi Sankyo Business Overview
Table 73. Daiichi Sankyo Novel Oral Anticoagulants Drugs Product
Table 74. Daiichi Sankyo Revenue in Novel Oral Anticoagulants Drugs Business (2018-2023) & (US$ Million)
Table 75. Daiichi Sankyo Recent Development
Table 76. Research Programs/Design for This Report
Table 77. Key Data Information from Secondary Sources
Table 78. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Novel Oral Anticoagulants Drugs Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Novel Oral Anticoagulants Drugs Market Share by Type: 2022 VS 2033
Figure 3. Direct Thrombin Inhibitor Features
Figure 4. Factor Xa Inhibitors Features
Figure 5. Global Novel Oral Anticoagulants Drugs Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Novel Oral Anticoagulants Drugs Market Share by Application: 2022 VS 2033
Figure 7. Hospital Case Studies
Figure 8. Drugs Stores Case Studies
Figure 9. Other Case Studies
Figure 10. Novel Oral Anticoagulants Drugs Report Years Considered
Figure 11. Global Novel Oral Anticoagulants Drugs Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Novel Oral Anticoagulants Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Novel Oral Anticoagulants Drugs Market Share by Region: 2022 VS 2033
Figure 14. Global Novel Oral Anticoagulants Drugs Market Share by Players in 2022
Figure 15. Global Top Novel Oral Anticoagulants Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Novel Oral Anticoagulants Drugs as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Novel Oral Anticoagulants Drugs Revenue in 2022
Figure 17. North America Novel Oral Anticoagulants Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Novel Oral Anticoagulants Drugs Market Share by Country (2018-2033)
Figure 19. United States Novel Oral Anticoagulants Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Canada Novel Oral Anticoagulants Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Novel Oral Anticoagulants Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Novel Oral Anticoagulants Drugs Market Share by Country (2018-2033)
Figure 23. Germany Novel Oral Anticoagulants Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. France Novel Oral Anticoagulants Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. U.K. Novel Oral Anticoagulants Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Italy Novel Oral Anticoagulants Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Russia Novel Oral Anticoagulants Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Nordic Countries Novel Oral Anticoagulants Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Novel Oral Anticoagulants Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Novel Oral Anticoagulants Drugs Market Share by Region (2018-2033)
Figure 31. China Novel Oral Anticoagulants Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Japan Novel Oral Anticoagulants Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. South Korea Novel Oral Anticoagulants Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Southeast Asia Novel Oral Anticoagulants Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. India Novel Oral Anticoagulants Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Australia Novel Oral Anticoagulants Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Novel Oral Anticoagulants Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Novel Oral Anticoagulants Drugs Market Share by Country (2018-2033)
Figure 39. Mexico Novel Oral Anticoagulants Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Brazil Novel Oral Anticoagulants Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Novel Oral Anticoagulants Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Novel Oral Anticoagulants Drugs Market Share by Country (2018-2033)
Figure 43. Turkey Novel Oral Anticoagulants Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Saudi Arabia Novel Oral Anticoagulants Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Bristol-Myers Squibb Revenue Growth Rate in Novel Oral Anticoagulants Drugs Business (2018-2023)
Figure 46. Bayer Revenue Growth Rate in Novel Oral Anticoagulants Drugs Business (2018-2023)
Figure 47. Pfizer Revenue Growth Rate in Novel Oral Anticoagulants Drugs Business (2018-2023)
Figure 48. Johnson & Johnson Revenue Growth Rate in Novel Oral Anticoagulants Drugs Business (2018-2023)
Figure 49. Boehringer Ingelheim Revenue Growth Rate in Novel Oral Anticoagulants Drugs Business (2018-2023)
Figure 50. Daiichi Sankyo Revenue Growth Rate in Novel Oral Anticoagulants Drugs Business (2018-2023)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed